Thorax

Article	Citations
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19	575
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort	398
Respiratory follow-up of patients with COVID-19 pneumonia	247
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms	220
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study	219
Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis	203
Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study	201
COVID-19: in the footsteps of Ernest Shackleton	140
Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease	135
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length	133
A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial	131
A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations	129
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey	126
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort	121
Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection	110
Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people	91
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19	89
BTS Clinical Statement on pulmonary sarcoidosis	89
Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p	86
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era	84
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19	84
Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS	80
Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review	77
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait	74
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide	69

Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales	68
Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data	65
Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study	64
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection	63
Severe organising pneumonia following COVID-19	60
Awake prone positioning in COVID-19	59
Night shift work is associated with an increased risk of asthma	58
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score	57
Neutrophils in asthma: the good, the bad and the bacteria	57
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)	57
Bacterial biofilms predominate in both acute and chronic human lung infections	55
Variation in oral microbiome is associated with future risk of lung cancer among never-smokers	51
Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19	50
Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases	50
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis	50
COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations	50
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case–control study	48
Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study	47
Applications of artificial intelligence and machine learning in respiratory medicine	47
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy	47
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)	45
Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysis	45
Shift work is associated with positive COVID-19 status in hospitalised patients	45
Face coverings and mask to minimise droplet dispersion and aerosolisation: a video case study	42
Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression	42
Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia	41
Identifying patients at risk of post-discharge complications related to COVID-19 infection	41
Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study	41
Induction of ferroptosis-like cell death of eosinophils exerts synergistic effects with glucocorticoids in allergic airway inflammation	40
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis	40
Balance impairment in individuals with COPD: a systematic review with meta-analysis	39
Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study	38
The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting	38
Pulmonary rehabilitation at a time of social distancing: prime time for tele-rehabilitation?	38
Long-term survival following initiation of home non-invasive ventilation: a European study	38
COPD assessment test for the evaluation of COVID-19 symptoms	37
Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome	37
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial	35
Reliability of methods to estimate the fraction of inspired oxygen in patients with acute respiratory failure breathing through non-rebreather reservoir bag oxygen mask	35
Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems	35
Role of unfolded proteins in lung disease	34
COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study	34
Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank	33
Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19	32
Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis	31
Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections	31
Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial	30
Association between COPD exacerbations and lung function decline during maintenance therapy	30
Blocking LOXL2 and TGFβ1 signalling induces collagen I turnover in precision-cut lung slices derived from patients with idiopathic pulmonary fibrosis	29
COVID-19 vaccine-related interstitial lung disease: a case study	29

Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis	29
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease	29
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis	29
Functional electrical stimulation in-bed cycle ergometry in mechanically ventilated patients: a multicentre randomised controlled trial	28
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial	28
Temperature variability and asthma hospitalisation in Brazil, 2000–2015: a nationwide case-crossover study	28
Role of extracellular vesicles in chronic lung disease	28
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures	28
Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1–3	27
Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation	27
British Thoracic Society Guideline for pleural disease	27
COPD-derived fibroblasts secrete higher levels of senescence-associated secretory phenotype proteins	27
Epidemiology and prognostic factors of pleural empyema	27
Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme	27
Relationship between asthma and severe COVID-19: a national cohort study	27
Cross-sectional and longitudinal associations between urinary zinc and lung function among urban adults in China	26
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects	26
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments	26
Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD	26
Frailty after lung transplantation is associated with impaired health-related quality of life and mortality	25
Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight	25
Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study	25
Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis	25
Use of inhaled corticosteroids and risk of acquiringPseudomonas aeruginosain patients with chronic obstructive pulmonary disease	25
Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial	25
Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis	25
Short-term association among meteorological variation, outdoor air pollution and acute bronchiolitis in children in a subtropical setting	25
Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies	25
Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis	25
Ambient air pollution exposure and chronic bronchitis in the Lifelines cohort	24
Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data	24
Sputum microbiota in adults with CF associates with response to inhaled tobramycin	24
Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score	24
Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007–2010)	24
Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis	24
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study	23
Different responses of the oral, nasal and lung microbiomes to cigarette smoke	23
Impact of lung function on cardiovascular diseases and cardiovascular risk factors: a two sample bidirectional Mendelian randomisation study	23
Increasing incidence of asbestosis worldwide, 1990–2017: results from the Global Burden of Disease study 2017	23
Burden of nosocomial COVID-19 in Wales: results from a multicentre retrospective observational study of 2508 hospitalised adults	23
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis	23
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study	23
Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial	23
Neural ventilatory drive decline as a predominant mechanism of obstructive sleep apnoea events	23
Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients	23
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol	23
Small airway determinants of airflow limitation in chronic obstructive pulmonary disease	22
Low vitamin D and risk of bacterial pneumonias: Mendelian randomisation studies in two population-based cohorts	22
Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial	22
Impact of chronic use of heat-not-burn cigarettes on oxidative stress, endothelial dysfunction and platelet activation: the SUR-VAPES Chronic Study	22
Delivering low-dose CT screening for lung cancer: a pragmatic approach	22
BTS Clinical Statement on air travel for passengers with respiratory disease	22
Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial	22
Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data	22
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	22
Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer	21
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study	21
Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study	21
Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients	21
Serum free testosterone and asthma, asthma hospitalisations and lung function in British adults	21
Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis	21
Longitudinal effects of ivacaftor and medicine possession ratio in people with theGly551Aspmutation: a 5-year study	20
Respiratory exacerbations are associated with muscle loss in current and former smokers	20
Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review	20
Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis	20
Ambient PM2.5exposure and hospital cost and length of hospital stay for respiratory diseases in 11 cities in Shanxi Province, China	20
Functional electrical stimulation‐assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up	20
Effects of Wnt signaling on epithelial to mesenchymal transition in chronic rhinosinusitis with nasal polyp	20
Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts	19
‘If not TB, what could it be?’ Chest X-ray findings from the 2016 Kenya Tuberculosis Prevalence Survey	19
Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening	19
Secondhand nicotine vaping at home and respiratory symptoms in young adults	19
Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis	19
Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis	18
Protective effect of club cell secretory protein (CC-16) on COPD risk and progression: a Mendelian randomisation study	18
Hormonal contraception and the risk of severe asthma exacerbation: 17-year population-based cohort study	18
Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives	18
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment	18
MTOR suppresses autophagy-mediated production of IL25 in allergic airway inflammation	18
Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis	18

Early-life risk factors for reversible and irreversible airflow limitation in young adults: findings from the BAMSE birth cohort	18
A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL)	18
Unlocking the secrets of long non-coding RNAs in asthma	18
BTS Clinical Statement on the prevention and management of community-acquired pneumonia in people with learning disability	18
Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis	18
Pulse arrival time, a novel sleep cardiovascular marker: the multi-ethnic study of atherosclerosis	18
Pretreatment of aged mice with retinoic acid supports alveolar regeneration via upregulation of reciprocal PDGFA signalling	17
Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy	17
Mesenchymal stromal/stem cells modulate response to experimental sepsis-induced lung injury via regulation of miR-27a-5p in recipient mice	17
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19	17
Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study	17
Greenness may improve lung health in low–moderate but not high air pollution areas: Seven Northeastern Cities’ study	17
Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma	17
Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort	17
Improved asthma control during the COVID-19 pandemic: are there lessons to be learnt?	16
Supervised pulmonary rehabilitation using minimal or specialist exercise equipment in COPD: a propensity-matched analysis	16
Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis	16
Asymptomatic SARS-CoV-2 infection: the tip or the iceberg?	16
Tension pneumomediastinum in patients with COVID-19	16
Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis	16
External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland	16
Diagnostic accuracy of focused deep venous, lung, cardiac and multiorgan ultrasound in suspected pulmonary embolism: a systematic review and meta-analysis	16
Exercise as a substitute for traditional airway clearance in cystic fibrosis: a systematic review	16
Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults	16
Nasal versus oronasal masks for home non-invasive ventilation in patients with chronic hypercapnia: a systematic review and individual participant data meta-analysis	16
Characterisation of gas exchange in COPD with dissolved-phase hyperpolarised xenon-129 MRI	16
Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study	16
Effect of exposure to fine particulate matter during pregnancy and infancy on paediatric allergic rhinitis	15
Use of preclinical models for malignant pleural mesothelioma	15
Associations of CT evaluations of antigravity muscles, emphysema and airway disease with longitudinal outcomes in patients with COPD	15
SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ	15
Longitudinal changes to quadriceps thickness demonstrate acute sarcopenia following admission to hospital for an exacerbation of chronic respiratory disease	15
Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease	15
Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling	15
Pleural recurrence after transthoracic needle lung biopsy in stage I lung cancer: a systematic review and individual patient-level meta-analysis	15
SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research	15
Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey	15
Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI	15
Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation	15
Parkin, an E3 ubiquitin ligase, enhances airway mitochondrial DNA release and inflammation	15
Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS	15
Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis	14
Cardiovascular outcomes in obstructive sleep apnoea and implications of clinical phenotyping on effect of CPAP treatment	14
Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019	14
Relationship between heart failure and the risk of acute exacerbation of COPD	14
Asthma diagnosis: into the fourth dimension	14
Caring for patients with COPD and COVID-19: a viewpoint to spark discussion	14
DNA methylation is associated with airflow obstruction in patients living with HIV	14
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma	14
Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers	14
Ceramide and sphingosine-1 phosphate in COPD lungs	14
A refresh of the top 10 research priorities in cystic fibrosis	14
Inconsistent relationship between depth of sedation and intensive care outcome: systematic review and meta-analysis	14
Selection of eligible participants for screening for lung cancer using primary care data	13
COVID-19 and what comes after?	13
Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity	13
Respiratory and allergic outcomes among 5-year-old children exposed to pesticides	13
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review	13
Lung Screen Uptake Trial: results from a single lung cancer screening round	13
Asthma and all-cause mortality in children and young adults: a population-based study	13
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study	13
Effect modification of greenness on PM2.5associated all-cause mortality in a multidrug-resistant tuberculosis cohort	13
Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers	13
Citizen science in the time of COVID-19	13
ABCA3-related interstitial lung disease beyond infancy	13
Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease	13
Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study	12
Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study	12
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension	12
Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia	12
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis	12
Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis	12
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials	12
Building a home ventilation programme: population, equipment, delivery and cost	12
Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study	12
Grandmaternal smoking, asthma and lung function in the offspring: the Lifelines cohort study	12
RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic	12
Maternal asthma is associated with reduced lung function in male infants in a combined analysis of the BLT and BILD cohorts	12
Use of oscillatory positive expiratory pressure (OPEP) devices to augment sputum clearance in COPD: a systematic review and meta-analysis	12
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial	12
Risk and impact of chronic cough in obese individuals from the general population	12
Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study	12
Cost-effectiveness of outpatient versus inpatient non-invasive ventilation setup in obesity hypoventilation syndrome: the OPIP trial	12
Associations of ultrafine and fine particles with childhood emergency room visits for respiratory diseases in a megacity	12
Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosis	12
Oxygen supplementation during exercise improves leg muscle fatigue in chronic fibrotic interstitial lung disease	12
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study	12
In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection	12
Role of the IL-33/ST2 axis in cigarette smoke-induced airways remodelling in chronic obstructive pulmonary disease	12
Testing the effects of combining azithromycin with inhaled tobramycin forP. aeruginosain cystic fibrosis: a randomised, controlled clinical trial	12
TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection	12
Essential role of smooth muscle Rac1 in severe asthma-associated airway remodelling	12
Five-year outcome of respiratory muscle weakness at intensive care unit discharge: secondary analysis of a prospective cohort study	12
Longitudinal follow-up of postacute COVID-19 syndrome: DLCO, quality-of-life and MRI pulmonary gas-exchange abnormalities	12